IceCure Medical (ICCM) has filed for regulatory approval with the Medical Device Division of Israel’s Ministry of Health for its single ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

IceCure Medical has submitted a regulatory filing to China's National Medical Products Administration (NMPA) seeking the approval of its ProSense cryoablation system, which is designed for minimally ...

Cryoablation was performed using contemporary technology (TRUS [transrectal ultrasound] guidance with argon/helium third-generation equipment), and the study protocol allowed the procedure to be ...

Researchers assessed the impact of cryoablation during lobectomy for lung cancer on opioid use, hospital costs, and patient outcomes.

Critical to the continual improvement of cryoablation efficacy is deciphering the biochemical responses of cells to low-temperature exposure. The identification of delayed-onset cell death has ...

CAESAREA, Israel, Jan. 27, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment ...

Application covering a wide range of indications is in line with trends in de-escalation of surgery and growth in minimally invasive cryoabla ...

CAESAREA, Israel, Jan. 27, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the ...